Gilead Sciences Inc
NASDAQ:GILD
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
American Express Co
NYSE:AXP
|
Financial Services
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Target Corp
NYSE:TGT
|
Retail
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
62.79
97.9
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Estee Lauder Companies Inc
NYSE:EL
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Church & Dwight Co Inc
NYSE:CHD
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
American Express Co
NYSE:AXP
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Target Corp
NYSE:TGT
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
Mueller Industries Inc
NYSE:MLI
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Gilead Sciences Inc
Wall Street
Price Targets
GILD Price Targets Summary
Gilead Sciences Inc
According to Wall Street analysts, the average 1-year price target for
GILD
is 88.97 USD
with a low forecast of 69.69 USD and a high forecast of 129.15 USD.
GILD Last Price Targets
Gilead Sciences Inc
The latest public price target was made on Nov 7, 2024 by
Joseph Catanzaro
from
Piper Sandler
,
who expects
GILD
stock to
rise by 13%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is GILD's stock price target?
Price Target
88.97
USD
According to Wall Street analysts, the average 1-year price target for
GILD
is 88.97 USD
with a low forecast of 69.69 USD and a high forecast of 129.15 USD.
What is Gilead Sciences Inc's Revenue forecast?
Projected CAGR
3%
For the last 8 years the
compound annual growth rate for
Gilead Sciences Inc's revenue is
-2%.
The projected
CAGR
for the next 3 years is
3%.
What is Gilead Sciences Inc's Operating Income forecast?
Projected CAGR
9%
For the last 8 years the
compound annual growth rate for
Gilead Sciences Inc's operating income is
-10%.
The projected
CAGR
for the next 3 years is
9%.
What is Gilead Sciences Inc's Net Income forecast?
Projected CAGR
20%
For the last 8 years the
compound annual growth rate for
Gilead Sciences Inc's net income is
-14%.
The projected
CAGR
for the next 3 years is
20%.
You don't have any saved screeners yet
